Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.6 USD | -3.48% | -8.26% | +39.75% |
08/05 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
08/05 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.75% | 2.08B | |
+3.25% | 108B | |
+11.07% | 104B | |
+1.25% | 22.33B | |
-11.98% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.05% | 17.64B | |
+5.15% | 14.05B | |
+34.39% | 12.51B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics Prices Stock Offering at $40 a Share